Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/21/2003US6635776 Lipoxin compounds and their use in treating cell proliferative disorders
10/21/2003US6635765 Processes for preparing torsemide intermediate
10/21/2003US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
10/21/2003US6635762 Monocyclic-7H-pyrrolo[2,3-d]pyrimidine compounds, compositions, and methods of use
10/21/2003US6635744 Substantially pure fibroblast growth factor homologous factor-4 polypeptide having specified amino acid sequence; diagnosis and treatment of neurodegenerative and neoplastic disorders
10/21/2003US6635679 Contacting the biological source (cells, blood, tissue etc.) with a solution of an amphipathic charged amine or an amine oxide, e.g., dimethylhexadecylamine, dimethyldecylamine oxide; purification; viricides
10/21/2003US6635678 Topical application of phenylephrine
10/21/2003US6635677 Potentiating toxicity of 1,3-bis(chloroethyl)2-nitrosourea
10/21/2003US6635676 Non-toxic antimicrobial compositions and methods of use
10/21/2003US6635675 Method of treating chronic fatigue syndrome
10/21/2003US6635674 Oleic acid and/or oleyl alcohol; increasing skin absorption
10/21/2003US6635673 1-Aminomethyl-3,4-dimethyl-cyclopentyl acetic acid; epilepsy; neurodegenerative, neuropathological and gastrointestinal disorders; depression, anxiety, panic, pain
10/21/2003US6635672 Agent for lowering prolactin
10/21/2003US6635671 Compounds which affect mRNA stability and uses therefor
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635668 Imidazoline receptor binding compounds
10/21/2003US6635667 Methods of treatment using MAO-A and MAO-B inhibitors such as L-deprenyl
10/21/2003US6635666 Cancer treatment with epothilones
10/21/2003US6635665 Acute respiratory distress syndrome and chronic obstructive pulmonary disease
10/21/2003US6635661 Heterocyclic analgesic compounds and methods of use thereof
10/21/2003US6635660 Methods of inhibiting sphincter incontinence
10/21/2003US6635658 Amino-tetralin derivatives as muscarinic receptor antagonists
10/21/2003US6635657 Pyridine derivatives; anticoagulants
10/21/2003US6635656 Cytotoxic alkaloids halitulin
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635654 Ophthalmic compositions containing loratadine
10/21/2003US6635653 Spiropyrazole compounds
10/21/2003US6635651 Inhibitors of thrombin induced platelet aggregation
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/21/2003US6635649 Piperazinedione compounds
10/21/2003US6635648 Combination therapy using sympathetic nervous system antagonists and endothelin antagonists
10/21/2003US6635647 Decahydro-isoquinolines
10/21/2003US6635646 Pegylated interferon alfa-CCR5 antagonist combination HIV therapy
10/21/2003US6635645 2,5,-diazabicyclo[2.2.1]heptane derivatives, their preparation and therapeutic uses
10/21/2003US6635644 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli
10/21/2003US6635643 For treating conditions which are related to impairment of gastric emptying
10/21/2003US6635642 Poly(ADP-ribose) polymerase inhibitors; tissue damage treatment
10/21/2003US6635641 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/21/2003US6635640 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
10/21/2003US6635639 Use of N-alkylamino-heterocylic compounds for the treatment of migraine
10/21/2003US6635638 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/21/2003US6635637 Cyclic oxyguanidine protease inhibitors
10/21/2003US6635635 Benzothiadiazine compounds
10/21/2003US6635633 Substituted pyrazoles useful for treating autoimmune diseases mediated by cathepsin S
10/21/2003US6635632 Alzheimer's disease
10/21/2003US6635631 Iron compounds, compositions, methods of making the same and uses thereof
10/21/2003US6635629 For therapy and prophylaxis of inflammation, asthma, an allergic disease, chronic obstructive pulmonary disease, atopic dermatitis, solid tumors, AIDS, ischemia, and cardiac arrhythmias
10/21/2003US6635628 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects
10/21/2003US6635627 Anti-cancer products for treating cystic fibrosis
10/21/2003US6635625 Chondroitin sulfate, quercetin, chitin D-glucosamine sulfate, crown sodium hyaluronate, rutin, olive kernel extract, lecithan, beeswax and water
10/21/2003US6635622 Having anti-tumor activity and immunostimulating activity
10/21/2003US6635619 Amino acid sequence 88, 96, 97, 98, 99 or 100; increasing serum and tissue levels of active component
10/21/2003US6635615 Stable salts of S-adenosyl-l-methionine
10/21/2003US6635614 Use of lecithin-cholesterol acyltransferase (LCAT) to reduce accumulation of cholesterol
10/21/2003US6635490 Mixing phytochemicals with solvents to make a crude plant extract; purifying and isolating through fractionation; liquid chromatography, electrospray ionization mass spectrometry and spectroscopy
10/21/2003US6635479 Hypothalamus-specific polypeptides
10/21/2003US6635476 Complex of recombinant virus-chelating peptide covalently linked to ligand through a transition metal ion; kinetically stable; use in delivering a therapeutic or diagnostic agent to a cell
10/21/2003US6635461 Encoded by isolated nucleic acid; has glycosyltransferase activity; given amino acid sequence; useful as diagnostic and therapeutic agent for cancer and thymus-related disorders
10/21/2003US6635451 Conversion of dihomo-gamma linolenic acid (DGLA) to arachidonic acid and in the conversion of 20:4n-3 to eicosapentaenoic acid (EPA); Delta 6 desaturase and Delta 5 desaturase
10/21/2003US6635431 Recombinant lipolysis stimulated (LSR) comprising polypeptide of given sequence; use for selecting a compound for enhancing lipoprotein uptake in cells expressing the polypeptide
10/21/2003US6635428 Oligonucleotides and methods for detecting hepatitis B viral nucleic acids
10/21/2003US6635284 Delivery of multiple doses of medications
10/21/2003US6635283 Biocompatible particles having therapeutic, prophylactic or diagnostic agent, and of given mass mean diameter and aerodynamic diameter; at least 46% of the mass of particles are deposited after the first bifurcation of the lungs
10/21/2003US6635279 Active ingredient-containing floating forms comprising polyvinyl acetate and polyvinylpyrrolidone, their use and production
10/21/2003US6635278 Nucleotide analog 9-(2-((bis((pivaloyloxy)methyl)phosphono)methoxy)ethyl) adenine and an alkaline excipient with or without L-carnitine-L- tartrate. The compositions are more stable
10/21/2003US6635277 Composition for pulsatile delivery of diltiazem and process of manufacture
10/21/2003US6635274 Solution-based transdermal drug delivery system
10/21/2003US6635273 Methods of treating vascular diseases characterized by nitric oxide insufficiency
10/21/2003US6635271 Feeding to the ruminant vaccenic acid, i.e. chemically precisely expressed the trans-11 isomer of octadecenoic acid (trans-11-C18:1). antitumor
10/21/2003US6635270 NMDA receptor agonist pharmaceutical compositions
10/21/2003US6635267 Biomedical material such as an injection for treatment of arthrosis, an embolizing material, an injection for a soft tissue and an artificial vitreous body.
10/21/2003US6635258 Herpes simplex virus VP22 vaccines and methods of use
10/21/2003US6635255 CASB414:antigen overexpressed in several tumors
10/21/2003US6635253 Composition for enhancing immunological effects
10/21/2003US6635250 Use of certain metalloproteinase inhibitors for treating nerve disorders mediated by nucleus pulpsus
10/21/2003US6635244 Adenovirus E1B-55K single amino acid mutants and methods of use
10/21/2003US6635242 Nursing bottle comprising container for breast milk, cap portion and nipple, and microbiocidal composition comprising sodium dodecyl sulfate, lithium dodecyl sulfate or lauric acid and salts in amount viricidal against non-enveloped virus
10/21/2003US6635237 Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substance dependence
10/21/2003US6635045 Silver/silver chloride; reservoir comprising aqueous sodium chloride dispersed therein; corrosion resistance; transdermal
10/21/2003CA2310318C Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride
10/21/2003CA2288003C Pharmaceutical compositions of tizoxanide and nitazoxanide
10/21/2003CA2257898C Use of aminothiolester derivatives in pharmaceutics
10/21/2003CA2251790C Methods of regulating skin appearance with vitamin b3 compound
10/21/2003CA2240136C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/21/2003CA2237401C Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides
10/21/2003CA2225352C Vegetable derived petroleum jelly replacement
10/21/2003CA2213737C 2-arylbenzazole compounds
10/21/2003CA2208714C Bone mass anabolic composition comprising olpadronate
10/21/2003CA2169376C Procedure for encapsulating nsaids
10/21/2003CA2158166C Delayed release microtablet of .beta.-phenylpropiophenone derivatives
10/21/2003CA2156825C Inhibition of intimal hyperplasia using antibodies to pdgf receptors
10/21/2003CA2153979C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
10/21/2003CA2141964C Pharmaceutical agents containing diphosphonic acids and salts thereof
10/21/2003CA2130926C Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof
10/21/2003CA2117883C Erythromycin derivatives
10/21/2003CA2114239C Pharmaceutical composition containing carbachol and other cholinergic substances
10/21/2003CA2098020C Anti-viral compounds
10/21/2003CA2081344C Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke
10/21/2003CA2060326C Antiarrhythmic tertiary amine-alkenyl-phenyl-alkanesulfonamides
10/21/2003CA2053924C Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
1 ... 5305 5306 5307 5308 5309 5310 5311 5312 5313 5314 5315 5316 5317 5318 5319 5320 5321 5322 5323 5324 5325 ... 7860